Bright Minds Biosciences ... (DRUG)

NASDAQ: DRUG · Real-Time Price · USD

31.64

1.02 (3.33%)

At close: May 02, 2025, 2:05 PM

Bright Minds Biosciences Cash Flow Statement

Financials in CAD. Fiscal year is October - September.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019
Net Income	-2.8M	-7.37M	-14.96M	-8.65M	-480.38K	-78.72K
Depreciation & Amortization	73.36K	72.45K	6.04K	n/a	n/a	n/a
Stock-Based Compensation	839.77K	1.15M	875.06K	880.62K	161.3K	n/a
Other Working Capital	39.81K	-941.72K	771.94K	416.23K	30.68K	36.71K
Other Non-Cash Items	-1.18K	65.1K	-229.57K	144.76K	161.3K	110.12K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	39.81K	-941.72K	726.31K	306.08K	30.68K	36.71K
Operating Cash Flow	-1.85M	-7.02M	-13.59M	-7.32M	-288.39K	-42.01K
Capital Expenditures	n/a	5.00	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a
Debt Repayment	-89.73K	-86.11K	-7.16K	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	302.00	1.06M	1.17M	-1.69M	n/a	366K
Financial Cash Flow	810.57K	2.19M	5.2M	26.06M	1.01M	122K
Net Cash Flow	-1.03M	-4.88M	-8.13M	18.96M	719.94K	79.99K
Free Cash Flow	-1.85M	-7.02M	-13.59M	-7.32M	-288.39K	-42.01K